Frequently Asked Questions
The market is segmented based on , By Administration (Injectable, Topical, Oral), Drug Type (Antibiotics, Antihistamines, Corticosteroids, Emollients, Calcineurin Inhibitors, Immunomodulators, Off-Label Therapies, Systemic Agents, PDE4 Inhibitor, Interleukin Inhibitor), End Users (Hospital, Clinic, Home Care), Distribution Channel (Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores, Pharmacies, Dermatology Clinics) - Industry Trends and Forecast to 2030.
.
The Global Atopic Dermatitis Treatment Market size was valued at USD 1426.44 USD Million in 2022.
The Global Atopic Dermatitis Treatment Market is projected to grow at a CAGR of 9.86% during the forecast period of 2023 to 2030.
The major players operating in the market include Boehringer Ingelheim International GmbH, AbbVie , Bayer AG, Bristol-Myers Squibb Company, Novartis AG, LEO Pharma A/S, Regeneron Pharmaceuticals , Astellas Pharma , Pfizer , GALDERMA LABORATORIES L.P., Sanofi, F. Hoffmann-La Roche , Encore Dermatology , GSK plc, AstraZeneca, Bausch Health Companies
-.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
